• Wed news: Merck - Modifi acquisition. Med device earnings. Lilly’s UK Alzheimer’s nod. Senators probe Lilly, Pfizer DTC Rxing. Regeneron loses bid to block Amgen Eylea biosim. See more on our front page

Current Entyvio Sales













It's been terrible! Far behind projections. Most doctors are happy with their Remicade or Humira. Another dog show product from Takeda. So glad I took this promotion.
 




















Christ the moles for hire are frothing at this thread. Clients that shamelessly scour these threads as well, are you reading this? Your highly paid 'research professionals' are laughable.
 




Back to topic: Also with me, no one wants to get patients from Humira or Remicade on Entyvio. ...and no new patients either, as they are so satisfied and do not trust a company what deletes safety data.

Any one with different experience?
 




















It takes too long for patients to see a difference with Entyvio. Patients/doctors are not sticking with it. They put patients back on Remicade or Humira. That's happening and that's not good.